Abstract
Polyaspartic acid (PAA) ameliorates experimental gentamicin nephrotoxicity despite marked accumulation of gentamicin in the renal cortex. The experiments described here probe the extent of PAA's nephroprotective action when increasing doses of gentamicin, in excess of an established nephrotoxic dose (40 mg/kg of body weight per day), are administered. After 10 days, virtually complete nephroprotection was conferred by PAA coadministered to animals receiving three times the nephrotoxic dose (120 mg/kg/day) of gentamicin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett W. M., Plamp C. E., Gilbert D. N., Parker R. A., Porter G. A. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis. 1979 Oct;140(4):576–580. doi: 10.1093/infdis/140.4.576. [DOI] [PubMed] [Google Scholar]
- English J., Gilbert D. N., Kohlhepp S., Kohnen P. W., Mayor G., Houghton D. C., Bennett W. M. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother. 1985 Jun;27(6):897–902. doi: 10.1128/aac.27.6.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilbert D. N., Wood C. A., Kohlhepp S. J., Kohnen P. W., Houghton D. C., Finkbeiner H. C., Lindsley J., Bennett W. M. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis. 1989 May;159(5):945–953. doi: 10.1093/infdis/159.5.945. [DOI] [PubMed] [Google Scholar]
- Kacew S. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat. J Pharmacol Exp Ther. 1989 Jan;248(1):360–366. [PubMed] [Google Scholar]
- Kikuchi S., Aramaki Y., Nonaka H., Tsuchiya S. Effect of dextran sulfate on renal accumulation of gentamicin. Pharm Res. 1990 Jun;7(6):644–647. doi: 10.1023/a:1015830614244. [DOI] [PubMed] [Google Scholar]
- Kojima R., Ito M., Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism. Jpn J Pharmacol. 1986 Nov;42(3):397–404. doi: 10.1254/jjp.42.397. [DOI] [PubMed] [Google Scholar]
- Kojima R., Ito M., Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (9): Protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity. Jpn J Pharmacol. 1990 Jul;53(3):347–358. doi: 10.1254/jjp.53.347. [DOI] [PubMed] [Google Scholar]
- Ramsammy L. S., Josepovitz C., Lane B. P., Kaloyanides G. J. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat. J Pharmacol Exp Ther. 1989 Jul;250(1):149–153. [PubMed] [Google Scholar]
- Swan S. K., Kohlhepp S. J., Kohnen P. W., Gilbert D. N., Bennett W. M. Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother. 1991 Dec;35(12):2591–2595. doi: 10.1128/aac.35.12.2591. [DOI] [PMC free article] [PubMed] [Google Scholar]